These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 30844812

  • 1. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG, Kraglund KL, Buttenschøn HN, Johnsen SP, Andersen G, Mortensen JK.
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [Abstract] [Full Text] [Related]

  • 2. The Serotonin Transporter Gene Polymorphisms and Risk of Ischemic Stroke.
    Mortensen JK, Kraglund KL, Johnsen SP, Mors O, Andersen G, Buttenschøn HN.
    Cerebrovasc Dis; 2018; 45(3-4):187-192. PubMed ID: 29614501
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
    Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH.
    Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
    [Abstract] [Full Text] [Related]

  • 6. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 7. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
    Oz MD, Baskak B, Uckun Z, Artun NY, Ozdemir H, Ozel TK, Ozguven HD, Suzen HS.
    Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
    [Abstract] [Full Text] [Related]

  • 8. SLC6A4 variation and citalopram response.
    Mrazek DA, Rush AJ, Biernacka JM, O'Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL, Snyder KA, Black JL, Weinshilboum RM.
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr 05; 150B(3):341-51. PubMed ID: 18618621
    [Abstract] [Full Text] [Related]

  • 9. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    Dombrovski AY, Mulsant BH, Ferrell RE, Lotrich FE, Rosen JI, Wallace M, Houck PR, Mazumdar S, Pollock BG.
    Int Clin Psychopharmacol; 2010 Jan 05; 25(1):37-45. PubMed ID: 19996755
    [Abstract] [Full Text] [Related]

  • 10. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.
    Lenze EJ, Goate AM, Nowotny P, Dixon D, Shi P, Bies RR, Lotrich FK, Rollman BL, Shear MK, Thompson PA, Andreescu C, Pollock BG.
    J Clin Psychopharmacol; 2010 Dec 05; 30(6):672-7. PubMed ID: 21105279
    [Abstract] [Full Text] [Related]

  • 11. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
    Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP.
    Biol Psychiatry; 2007 Mar 15; 61(6):734-42. PubMed ID: 17123473
    [Abstract] [Full Text] [Related]

  • 12. Prestroke Physical Activity and Poststroke Cognitive Performance.
    Damsbo AG, Mortensen JK, Kraglund KL, Johnsen SP, Andersen G, Blauenfeldt RA.
    Cerebrovasc Dis; 2020 Mar 15; 49(6):632-638. PubMed ID: 33176308
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M, Huang CY, Wang F.
    J Stroke Cerebrovasc Dis; 2018 Nov 15; 27(11):2905-2918. PubMed ID: 30201459
    [Abstract] [Full Text] [Related]

  • 14. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
    Ruhé HG, Ooteman W, Booij J, Michel MC, Moeton M, Baas F, Schene AH.
    Pharmacogenet Genomics; 2009 Jan 15; 19(1):67-76. PubMed ID: 18987562
    [Abstract] [Full Text] [Related]

  • 15. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
    Seripa D, Pilotto A, Paroni G, Fontana A, D'Onofrio G, Gravina C, Urbano M, Cascavilla L, Paris F, Panza F, Padovani A, Pilotto A.
    J Psychopharmacol; 2015 May 15; 29(5):623-33. PubMed ID: 25827644
    [Abstract] [Full Text] [Related]

  • 16. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H, Haddjeri N, Sánchez C.
    Psychopharmacology (Berl); 2012 Jan 15; 219(1):1-13. PubMed ID: 21901317
    [Abstract] [Full Text] [Related]

  • 17. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
    Manoharan A, Shewade DG, Rajkumar RP, Adithan S.
    Eur J Clin Pharmacol; 2016 Oct 15; 72(10):1215-1220. PubMed ID: 27439447
    [Abstract] [Full Text] [Related]

  • 18. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
    Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH.
    J Affect Disord; 2016 May 15; 196():11-9. PubMed ID: 26896742
    [Abstract] [Full Text] [Related]

  • 19. Depressive Symptoms in Stroke Patients: Are There Sex Differences?
    Lee EJ, Kim JS, Chang DI, Park JH, Ahn SH, Cha JK, Heo JH, Sohn SI, Lee BC, Kim DE, Kim HY, Kim S, Kwon DY, Kim J, Seo WK, Lee J, Park SW, Koh SH, Kim JY, Choi-Kwon S.
    Cerebrovasc Dis; 2020 May 15; 49(1):19-25. PubMed ID: 32023608
    [Abstract] [Full Text] [Related]

  • 20. Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population.
    Mandal T, Bairy LK, Sharma PSVN.
    Eur J Clin Pharmacol; 2020 Jun 15; 76(6):807-814. PubMed ID: 32253447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.